Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy. (Q43152906)

From Wikidata
Jump to: navigation, search
scientific article published in February 2010
edit
Language Label Description Also known as
English
Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy.
scientific article published in February 2010

    Statements

    Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy. (English)
    0 references
    Demir Ozbasar
    Ummuhan Toros
    Okan Ozkaya
    Hafize Uzun
    Habibe Genc
    Hakan Kaya
    1 February 2010
    133-137

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit